PRINCETON, N. J., USA, and Berlin, Germany, June 25, 2012 — SCIENION US, Inc. today announced that Courtagen Life Sciences, Inc. – a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry – will use SCIENION’s sciFLEXARRAYER technology to produce innovative biochips for multiplex immunoassays, and collaborate with Scienion to meet future manufacturing and market needs.
Dortmund and Berlin, Germany, June 25, 2012: “With its novel protein immunoassay platform, QPDx® BioChip, Courtagen has brought a fantastic product to market which has already proven to be successful for biomarker analysis in a variety of applications. We are very pleased that Courtagen, with its highly experienced team, has decided to use our sciFLEXARRAYER S11 to produce these biochips”, said Dr. Holger Eickhoff, Chief Executive Officer of SCIENION AG. “And with our new US subsidiary SCIENION US, Inc. we are well prepared to provide great service and extend the collaboration according to future needs of our new customer.”
Courtagen Life Sciences, Inc. has developed an automated immunoassay system that consists of a self-contained array-based QPDx® BioChip and the Avantra® Q400 Biomarker Workstation. The system provides a simple and robust solution to the need to translate proteomics discoveries into a clinical setting. The self-contained BioChip, one step operation, and short time to results make this technology ideally suited for testing at the point of sample collection, enabling real-time application of biomarker results. The Avantra Q400 is a compact bench top instrument suitable for space limited areas enabling multiplex biomarker analysis for research use only (RUO) at the lab bench or clinical trial site.
“We have been looking for a reliable solution for the reproducible high throughput production of spotted arrays for our QPDx® BioChips,” said Dr. Kate Sheldon, Ph.D., Director of Product Development at Courtagen. “The SCIENION sciFLEXARRAYER S11 is able to consistently produce high quality arrays that meet our needs, and has the capacity to meet demand as our business grows.”
About Courtagen Life Sciences, Inc.
Courtagen Life Sciences is a privately held life science company that provides innovative proteomic and genomic products and services to the life sciences industry. Founded by innovators in next-generation sequencing (NGS), genetics, molecular biology, and information science, Courtagen Life Sciences, Inc. delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. Courtagen provides proteomic and genomic solutions through its various operating divisions. More information can be found at www.courtagen.com.
Courtagen Life Sciences, Inc.
Elizabeth Holland ,Vice President
Scienion AG and its US subsidiary Scienion US, Inc. provide systems and services for the contact-free printing of biological and chemical agents for diagnostics, pharmaceutics, veterinary, plant and food analytics and research. Addressing the dynamically increasing needs for miniaturization and multiplex analyses, Scienion offers a unique technology portfolio that has been consequently expanded over one decade. Scienion provides flexible solutions for research and development whereas solutions for production purposes are rather customized. Systems and software are characterized by its versatility, precision and robustness. The company is a renowned specialist for ultra low volume liquid handling, particularly for the handling of precious and sensitive compounds of biological or chemical origin. Scienion’s dispensers allow for contact-free and precise drop spotting in the pico- to micro-liter range and are optimally suited for microarray based analytics – as for tests with DNA, oligonucleotides, peptides, proteins, antibodies, glycans or for dispensing cells onto various carriers.
The company operates from two sites in Germany, Dortmund and Berlin, and has a subsidiary in Princeton, New Jersey, USA.
Phone +49 (0)30 – 6392 1700
Fax: +49 (0)30 – 6392 1701